Cheaper private Covid jabs may end up as costly as pricier ones, say experts
by Nicola Davis Science correspondent from Science | The Guardian on (#6KSGC)
Exclusive: Multi-dose vials could push up charge per patient, with experts warning cost could widen inequalities
Cheaper private Covid jabs could end up being just as expensive as their pricier alternative because the vaccine must be given in groups of five, experts have warned.
Boots and pharmacies that partner with the company Pharmadoctor are offering Pfizer/BioNTech jabs to those not eligible for a free vaccination through the NHS, with the former charging almost 100 a shot. The latter is also offering the latest Novavax jab, a protein-based vaccine, at a cost of about 50.
Continue reading...